Enhancing endogenous adenosine A
Adenosine
/ analogs & derivatives
Adenosine A2 Receptor Agonists
/ chemical synthesis
Allosteric Regulation
Animals
Blood Pressure
/ drug effects
Body Temperature
/ drug effects
CHO Cells
Cricetulus
Drug Evaluation, Preclinical
Heart Rate
/ drug effects
Hypnotics and Sedatives
/ pharmacology
Male
Mice, Inbred C57BL
Mice, Knockout
Phenethylamines
/ pharmacology
Random Allocation
Receptor, Adenosine A2A
/ genetics
Signal Transduction
/ drug effects
Sleep, Slow-Wave
/ drug effects
Wakefulness
/ drug effects
Adenosine A(2A) receptor
Allosteric modulator
Body temperature
Cardiovascular function
Insomnia
Slow-wavesleep
Journal
Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
07
05
2018
revised:
10
10
2018
accepted:
14
10
2018
pubmed:
20
10
2018
medline:
5
3
2019
entrez:
19
10
2018
Statut:
ppublish
Résumé
Insomnia is one of the most common sleep problems with an estimated prevalence of 10%-15% in the general population. Although adenosine A
Identifiants
pubmed: 30336152
pii: S0028-3908(18)30807-4
doi: 10.1016/j.neuropharm.2018.10.022
pii:
doi:
Substances chimiques
Adenosine A2 Receptor Agonists
0
Hypnotics and Sedatives
0
Phenethylamines
0
Receptor, Adenosine A2A
0
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine
120225-54-9
Adenosine
K72T3FS567
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
122-132Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2018 Elsevier Ltd. All rights reserved.